Updates
Supporting the Public & Global Health Community in the Wake of Recent Events
Stemming the Loss of Critical Work, Talent, and Institutional Knowledge in Public Health (both US and Global) and Finding New Ways Forward to Advance Humanity’s Health
We are in unprecedented times. The recent and ongoing changes to public and global health funding and leadership puts at critical and immediate risk the ongoing programs and projects that improve the lives of people around the world. Also at risk is losing the community of talent and expertise driving this work, and the energies and ideas the individuals in this community possess.
To the public and global health leaders, including all supporting organizations, who have been impacted by recent events:
You have dedicated years of life-saving, health-building work domestically and abroad. First of all, thank you for your service. We must find ways to support each other and to continue to advance, regardless of recent events, our shared mission and vision. There is also an urgent need to capture the foundational knowledge you possess before it is lost.
20 Things We Should Redesign in 2025 for a Healthier, More Secure World
Jan 7, 2025 | Spoiler alert: Most of these solutions don't require massive investments in new technology – just bold entrepreneurs, solid business models, and good design.
As we navigate an increasingly complex world, some of our most pressing health challenges don't need breakthrough technologies or billions in research funding. Instead, they require thoughtful redesign of incentives, existing systems and tools. Here are 20 areas we at Humanity Health Ventures think are ripe for innovation in 2025…
Building Towards Humanity Health
Nov 21, 2024 | During the depths of the COVID-19 pandemic, I built and led a new research and development unit within BARDA, the U.S. agency responsible for funding vaccines, diagnostics, and medicines for public health emergencies. BARDA (the Biomedical Advanced Research and Development Authority) was supporting, among many other efforts, the commercialization of the world’s first mRNA vaccine. The unit I led, DRIVe, was created to take a longer view, one beyond the current COVID-19 health emergency, to fund a range of science and technology technologies that had the potential to fundamentally transform our ability to respond to future health emergencies…